eNeura, Inc. Receives FDA Clearance for Use of SpringTMSĀ® for Migraine Prevention

8 September 2017

eNeura, Inc., a privately held medical technology company, announced today that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) that states:  "The eNeura